Related Experiment Video
Updated: Jun 8, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
The global status of bioequivalence trials: a comprehensive clinical trial landscape analysis based on the Trialtrove
Xiuxin Zhong1, Shaojing Lin1, Mingxia Deng2
1The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan 523000, China.
Abstract:
This study presents a comprehensive analysis of the global bioequivalence (BE) trial landscape over the past 21 years, utilizing data from the Trialtrove database. We analyzed 12,450 BE trials conducted from 2003 to 2023, revealing a significant upward trend in trial numbers. Among the analysis, the primary therapeutic areas identified were cardiovascular diseases (23.17%) and metabolic/endocrinology conditions (18.91%). China leads in BE trials, accounting for 57.20% of the total, followed by Russia and the United States. Most trials are sponsored by the industry, predominantly by generic pharmaceutical companies. This study highlights the importance of diverse representation in trial populations to enhance the validity of results. We discuss strategies for improving trial success rates, including preliminary trials and in vitro dissolution testing. Furthermore, the need for international harmonization of generic drug standards is emphasized, along with the potential impact of advanced technologies, such as artificial intelligence, on future BE research.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Clinical Trials: Overview
Bioequivalence: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioavailability: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview